{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:30Z","timestamp":1790870490404,"version":"4.1.0"},"reference-count":9,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"abstract":"<jats:p>This Perspective urges multimodal management of obesity that extends beyond pharmacological treatment to screening, early management, and intensive behavioral therapy across the life course.<\/jats:p>","DOI":"10.1001\/jama.2026.16540","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:38:50Z","timestamp":1790869130000},"source":"Crossref","is-referenced-by-count":0,"title":["Building Effective Multimodal Care for Obesity and Comorbidities in the GLP-1 Therapy Era"],"prefix":"10.1001","author":[{"given":"Francesca","family":"Celletti","sequence":"first","affiliation":[{"name":"Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Manne-Goehler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Victor Ariel","family":"Franco","sequence":"additional","affiliation":[{"name":"Institute of General Practice, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Maria","family":"De Regil","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"10431","key":"jpp260034r1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","journal-title":"Lancet"},{"issue":"8114","key":"jpp260034r2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-026-10383-0","article-title":"Obesity rise plateaus in developed nations and accelerates in developing nations.","volume":"653","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2026","journal-title":"Nature"},{"issue":"5","key":"jpp260034r3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1001\/jama.2025.24288","article-title":"World Health Organization Guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults.","volume":"335","author":"Celletti","year":"2026","journal-title":"JAMA"},{"issue":"4","key":"jpp260034r5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S2213-8587(25)00395-X","article-title":"Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes.","volume":"14","author":"Nguyen","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"jpp260034r6","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2026.4106","article-title":"Lifestyle modification and incretin-based therapy for obesity.","volume":"335","author":"Kushner","year":"2026","journal-title":"JAMA"},{"issue":"4","key":"jpp260034r7","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1016\/S2214-109X(25)00496-6","article-title":"From endorsement of the WHO Acceleration Plan to Stop Obesity to national implementation: country progress on health system preparedness to scale up a comprehensive obesity chronic care programme.","volume":"14","author":"Celletti","year":"2026","journal-title":"Lancet Glob Health"},{"key":"jpp260034r4","unstructured":"WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults. World Health Organization. December 2025.  https:\/\/app.magicapp.org\/#\/guideline\/LrRxrL?"},{"key":"jpp260034r8","unstructured":"Brunei Darussalam becomes the first WHO member state to pilot obesity chronic care training. World Health Organization. March 4, 2026. https:\/\/www.who.int\/westernpacific\/newsroom\/feature-stories\/item\/brunei-darussalam-becomes-the-first-who-member-state-to-pilot-obesity-chronic-care-training"},{"key":"jpp260034r9","unstructured":"Beyond weight management: WHO and China advance system-based approaches to obesity prevention and care. World Health Organization. June 3, 2026. https:\/\/www.who.int\/china\/news\/feature-stories\/item\/beyond-weight-management--who-and-china-advance-system-based-approaches-to-obesity-prevention-and-care"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2854744\/jama_celletti_2026_pp_260034_1790286091.25335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:38:52Z","timestamp":1790869132000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2854744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1001\/jama.2026.16540","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}